DASA (DASA3) Main Indicators
Basic Data - DASA3
| Company | DASA |
| Corporate Name | DIAGNOSTICOS DA AMERICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Medicina Diagnóstica. Hospitais e Oncologia. |
| Share | DASA3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 2.30 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.75 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | GPTW, IBRA, ICON, IGC, IGCT, IGNM, ISE, ITAG, SMLL |
| Updated 11/21/2024 | |
Relative Prices - DASA3
| Price/Earnings | -1.97 |
| Price/SBV | 0.20 |
| Price/Net Sales | 0.12 |
| Price/CFO | -7.40 |
| Price/FCF | -2.72 |
| Price/Total Assets | 0.06 |
| Price/EBIT | 1.50 |
| Price/Working Capital | 0.46 |
| Price/NCAV | -0.11 |
| EV/EBIT | 9.19 |
| EV/EBITDA | 4.29 |
| EV/Net Sales | 0.71 |
| EV/CFO | -45.20 |
| EV/FCF | -16.64 |
| EV/Total Assets | 0.37 |
| Company Market Cap | R$ 1.73 B |
| Enterprise Value | R$ 10.58 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 2.30 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - DASA3
| Net Revenue | R$ 14.97 B |
| Gross Result | R$ 3.99 B |
| EBIT | R$ 1.15 B |
| Depreciation and Amortization | - R$ 1.31 B |
| EBITDA | R$ 2.47 B |
| Net Profit | - R$ 877.20 M |
| Net Profit/Share | - R$ 1.17 |
| Updated 11/13/2024 | |
| Net Revenue | R$ 3.97 B |
| Gross Result | R$ 1.14 B |
| EBIT | R$ 441.26 M |
| Depreciation and Amortization | - R$ 309.95 M |
| EBITDA | R$ 751.21 M |
| Net Profit | - R$ 87.49 M |
| Profit/Share | - R$ 0.12 |
| Updated 11/13/2024 | |
Price and Volume Behavior - DASA3
| Lowest Price 52 weeks | R$ 2.15 |
| Highest Price 52 weeks | R$ 10.29 |
| Variation 2024 | -74.92% |
| Variation 1 year | -77.65% |
| Variation 2 years(total) | -85.23% |
| Variation 2 years(yearly) | -61.47% |
| Variation 3 years(total) | -93.75% |
| Variation 3 years(yearly) | -60.28% |
| Variation 4 years(total) | -96.09% |
| Variation 4 years(yearly) | -55.54% |
| Variation 5 years(total) | -94.74% |
| Variation 5 years(yearly) | -44.46% |
| Average Daily Volume (3 months) | R$ 2.36 M |
| Updated 11/21/2024 | |
Returns and Margins - DASA3
| Return on Initial Tangible Capital | 7.38% |
| Return on Initial Invested Capital | 4.22% |
| Pre-Tax Return on Initial Tangible Capital | 11.18% |
| Pre-Tax Return on Initial Invested Capital | 6.40% |
| Return on Initial Shareholder´s Equity | -11.04% |
| Return on Initial Asset | -3.24% |
| Gross Margin | 26.62% |
| Net Margin | -5.86% |
| EBIT Margin | 7.69% |
| EBITDA Margin | 16.47% |
| Initial Asset Turnover | 0.55 |
| Financial Leverage | 3.28 |
| Liabilities/Net Worth | 2.28 |
| Net Debt/EBITDA | 3.59 |
| Updated 11/13/2024 | |
Balance Sheet - DASA3
| Cash and Cash Equivalents | R$ 2.70 B |
| Total Assets | R$ 28.29 B |
| Short-Term Debt | R$ 1.66 B |
| Long-Term Debt | R$ 9.89 B |
| Gross Debt | R$ 11.55 B |
| Net Debt | R$ 8.85 B |
| Shareholder´s Equity | R$ 8.62 B |
| Share Book Value | R$ 11.45 |
| Common Shares | 752,799,844 |
| Preferred Shares | 0 |
| Total | 752,799,844 |
| Common Shares in Treasury | 5,361,750 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 5,361,750 |
| Common Shares (Except Treasury) | 747,438,094 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 747,438,094 |
| Updated 11/13/2024 | |
Cash Flow - DASA3
| Operating Cash Flow | - R$ 234.07 M |
| Cash Flow from Investments | R$ 378.57 M |
| Financing Cash Flow | R$ 1.25 B |
| Increase (Reduction) in Cash and Equivalents | R$ 1.40 B |
| Updated 11/13/2024 | |
| Operating Cash Flow | R$ 226.65 M |
| Cash Flow from Investments | - R$ 77.59 M |
| Financing Cash Flow | - R$ 323.92 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 174.86 M |
| Updated 11/13/2024 | |
Experimental - DASA3
| CAPEX 3 months | - R$ 66.22 M |
| Free Cash Flow 3 months | R$ 160.43 M |
| CAPEX 12 months | - R$ 401.64 M |
| Free Cash Flow 12 months | - R$ 635.70 M |
| Updated 11/13/2024 | |